0001437749-23-006909.txt : 20230316 0001437749-23-006909.hdr.sgml : 20230316 20230316162808 ACCESSION NUMBER: 0001437749-23-006909 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230314 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bausch Christoph Lawrence CENTRAL INDEX KEY: 0001889981 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 23739189 MAIL ADDRESS: STREET 1: 2100 E 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 BUSINESS PHONE: 605-679-6980 MAIL ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 4 1 rdgdoc.xml FORM 4 X0306 4 2023-03-14 0001833214 SAB Biotherapeutics, Inc. SABS 0001889981 Bausch Christoph Lawrence 2100 E 54TH STREET NORTH SIOUX FALLS SD 57104 1 Chief Operating Officer Employee Stock Option (right to buy) 0.54 2023-03-14 4 A 0 275000 0 A 2033-03-14 Common Stock 275000 275000 D Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter. /s/ Christoph Bausch 2023-03-16